{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:06:00Z","timestamp":1795010760134,"version":"4.9.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["no. 22K09793"],"award-info":[{"award-number":["no. 22K09793"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Subretinal fibrosis is a major cause of vision loss during macular neovascularization (MNV) treatment. This study investigated the effect of the pachychoroid phenotype on subretinal fibrosis development after antivascular endothelial growth factor therapy for MNV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 107 eyes from 107 patients (63 males, 44 females; mean age 72.9 \u00b1 8.8 years) treated with antivascular endothelial growth factor therapy for MNV and followed for at least 4 years were included. Univariate and multivariate analyses identified factors associated with subretinal fibrosis at 4 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Subretinal fibrosis developed in 18 eyes (16.8%) after 4 years of therapy. Fibrosis occurred more frequently in eyes with type 2 MNV (44.4%) and subretinal hemorrhage (88.9%) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.026 and 0.001, respectively). The incidence of fibrosis did not differ between eyes with and without pachychoroid features (14.8% vs. 18.9%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.614). Logistic regression identified subretinal hemorrhage, type 2 MNV, and taller pigment epithelium detachment as significant factors (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0424, 0.0193, and 0.0149, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In addition to subretinal hemorrhage and type 2 MNV, taller pigment epithelium detachment was associated with subretinal fibrosis. The pachychoroid phenotype was neither a promoting nor protective factor for fibrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004569","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T16:00:10Z","timestamp":1751040010000},"page":"2035-2041","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["PACHYCHOROID NEITHER PROMOTES NOR INHIBITS THE FORMATION OF FIBROSIS IN MACULAR NEOVASCULARIZATION"],"prefix":"10.1097","volume":"45","author":[{"given":"Akari","family":"Oka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuya","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugao","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0977-9458","authenticated-orcid":false,"given":"Akio","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251021","doi-asserted-by":"crossref","first-page":"106250","DOI":"10.1016\/j.nbd.2023.106250","article-title":"Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium","volume":"185","author":"Liu","year":"2023","journal-title":"Neurobiol Dis"},{"key":"R2-20251021","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1159\/000524942","article-title":"Pathophysiology of age-related macular degeneration: implications for treatment","volume":"65","author":"Garcia-Garcia","year":"2022","journal-title":"Ophthalmic Res"},{"key":"R3-20251021","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","article-title":"Age-related macular degeneration","volume":"105","author":"Thomas","year":"2021","journal-title":"Med Clin North Am"},{"key":"R4-20251021","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/jamaophthalmol.2020.1376","article-title":"Characterization of drusen and hyperreflective foci as biomarkers for disease progression in age-related macular degeneration using artificial intelligence in optical coherence tomography","volume":"138","author":"Waldstein","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"R5-20251021","first-page":"Cd005139","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"3","author":"Solomon","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20251021","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s12325-020-01236-x","article-title":"Efficacy and safety of intravitreal aflibercept treat-and-extend regimens in exudative age-related macular degeneration: 52- and 96-week findings from ALTAIR: a randomized controlled trial","volume":"37","author":"Ohji","year":"2020","journal-title":"Adv Ther"},{"key":"R7-20251021","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-year outcomes in ranibizumab-treated patients in Anchor, Marina, and HORIZON: a multicenter cohort study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"R8-20251021","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1111\/aos.14905","article-title":"The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world","volume":"100","author":"Llorente-Gonz\u00e1lez","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"R9-20251021","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","article-title":"Risk of scar in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Daniel","year":"2014","journal-title":"Ophthalmology"},{"key":"R10-20251021","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2013.02.012","article-title":"Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab","volume":"156","author":"Bloch","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R11-20251021","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ophtha.2018.01.004","article-title":"Development and course of scars in the comparison of age-related macular degeneration treatments trials","volume":"125","author":"Daniel","year":"2018","journal-title":"Ophthalmology"},{"key":"R12-20251021","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/IAE.0000000000002779","article-title":"Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration","volume":"40","author":"Teo","year":"2020","journal-title":"Retina"},{"key":"R13-20251021","doi-asserted-by":"crossref","first-page":"12052","DOI":"10.1038\/s41598-021-91589-2","article-title":"Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy","volume":"11","author":"Yoon","year":"2021","journal-title":"Sci Rep"},{"key":"R14-20251021","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00417-017-3888-2","article-title":"Subfoveal choroidal thickness predicts macular atrophy in age-related macular degeneration: results from the TREX-AMD trial","volume":"256","author":"Fan","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R15-20251021","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10384-020-00740-5","article-title":"Pachychoroid disease: a new perspective on exudative maculopathy","volume":"64","author":"Yanagi","year":"2020","journal-title":"Jpn J Ophthalmol"},{"key":"R16-20251021","doi-asserted-by":"crossref","first-page":"18423","DOI":"10.1038\/s41598-020-75451-5","article-title":"Deep phenotype unsupervised machine learning revealed the significance of pachychoroid features in etiology and visual prognosis of age-related macular degeneration","volume":"10","author":"Hosoda","year":"2020","journal-title":"Sci Rep"},{"key":"R17-20251021","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/11206721211036290","article-title":"Pachychoroid neovasculopathy: a comparative review on pathology, clinical features, and therapy","volume":"32","author":"Sagar","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"R18-20251021","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transpl"},{"key":"R19-20251021","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ajo.2023.03.033","article-title":"Ten-year incidence of fibrosis and risk factors for its development in neovascular age-related macular degeneration","volume":"252","author":"Romano","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"R20-20251021","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00441-021-03514-8","article-title":"Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives","volume":"387","author":"Tenbrock","year":"2022","journal-title":"Cell Tissue Res"},{"key":"R21-20251021","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.3390\/cells11213453","article-title":"A linkage between angiogenesis and inflammation in neovascular age-related macular degeneration","volume":"11","author":"Heloter\u00e4","year":"2022","journal-title":"Cells"},{"key":"R22-20251021","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.7150\/ijbs.49890","article-title":"The role of inflammation in Age-related macular degeneration","volume":"16","author":"Tan","year":"2020","journal-title":"Int J Biol Sci"},{"key":"R23-20251021","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1038\/s41598-018-28484-w","article-title":"Distinct aqueous humour cytokine profiles of patients with pachychoroid neovasculopathy and neovascular age-related macular degeneration","volume":"8","author":"Terao","year":"2018","journal-title":"Sci Rep"},{"key":"R24-20251021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","volume":"144","author":"Maruko","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R25-20251021","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/IAE.0000000000003935","article-title":"Pigment epithelial detachment thickness and variability affects visual outcomes in patients with neovascular age-related macular degeneration","volume":"44","author":"Sarraf","year":"2024","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:00:47Z","timestamp":1761073247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004569","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}